Induction of primary hepatic tumours by diethylnitrosamine (DEN) treatment in Phd2+/− mice resulted in enhanced hepatocarcinogenesis and increased development of cholangiocarcinoma with a larger number of metastasis, which was suggested to be caused by chronic HIF activation [49]. Here, EGLN1 is linked to cholangiocarcinoma.